u PK-PD Modeling of irbesartan in healthy Chinese adult volunteers under non-steady-state condition. Eur J Drug Metab Pharmacokinet 2006;31(4)259-264

u Pharmacokinetic and pharmacodynamic population modeling of orally administered rabeprazole in healthy Chinese volunteers by the NONMEN method.European Journal of Drug Metabolism and Pharmacokinetics 2006; 31(1): 27-33

u Dynamics of drug combination: population models, computer simulation, and an application in the combinations of midazolam and propofol. Asian J Clin Pharmacol Exper Ther 2005;2(2):77-86

u Combined therapy of allantoin, metronidazole, dexamethasone on the prevention of intra-abdominal adhesion in dogs and its quantitative analysis. World J Gastroenterol 2003; 9(3): 568-571

u A method of comprehensive evaluation of multiple variables in drug interaction. Indian J Pharmacol 2001; 33: 445-451

u Quantitative design of optimal analgesic combination of acetaminophen, caffeine, and butalbital. Acta Pharmacol Sin 2001; 22(8): 691-696

u A novel animal model of intra-abdominal adhesion and quantitative evaluation with related indices. Chin J Clin Pharmacol Ther 2000; 5(2): 101-105

u Analysis of drug interactions in combined therapy by reflection method. Acta Pharmacol Sin 2000; 21(2): 183-187

u 头孢噻肟钠他唑巴坦钠注射液静脉滴注在健康志愿者的临床药代动力学研究及其算法探讨. 中国临床药理学与治疗学 2005; 10(11): 1225 -1230

u 新药临床研究中的可变剂量设计. 中国临床药理学与治疗学 2005; 10(4): 479 -480

u 群体药代动力学及其在新药研究中的应用. 中国临床药理学与治疗学 2004; 9(12): 1333-4

u 新药临床试验样本估计的简捷算法和等效标准探讨.中国新药杂志 2003；12(5): 368-371

u 纳米红色元素硒与葡萄糖醛酸内酯联用对大鼠肝纤维化形成过程的干预及其定量分析. 中国药理学通报. 2002; l8(1)

u 药效指标等级划分的常见问题及其数据处理. 中国临床药理学与治疗学 2002; 7(5): 469-472

u 临床两组药物等效的判别方法及其辨析. 中国临床药理学与治疗学 2002; 7(6): 559-561